Fungal problems in toenails is definitely not a "sexy" area, but one with real needs, and probably a growing one with aging populations. A novel tech with a committed team (with key experience in this biotech space) working methodically towards proving efficacy of the tech and leading it to commercialisation, sounds good to me.
- Forums
- ASX - By Stock
- Ann: Media Interview and Investor Presentation
Fungal problems in toenails is definitely not a "sexy" area, but...
Featured News
Add HXL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $1.837M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $2.475K | 225K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 378054 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 378054 | 0.009 |
3 | 750115 | 0.008 |
3 | 1057270 | 0.007 |
4 | 833135 | 0.006 |
1 | 300000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 25000 | 1 |
0.012 | 50205 | 1 |
0.014 | 485433 | 1 |
0.018 | 350000 | 1 |
0.029 | 131000 | 1 |
Last trade - 10.56am 03/07/2024 (20 minute delay) ? |
Featured News
HXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online